Latest NewsReproductive Freedom for All Condemns FDA for Moving Ahead with “Sham” Review of Mifepristone ChaseJune 15, 2026 New leadership at Trump’s Food and Drug Administration (FDA) confirmed that the agency is rushing through its politically motivated review of mifepristone ahead of critical midterm elections. Abortion PillsFDAGOPmifepristoneTrump
